Literature DB >> 11082111

Lack of involvement of endothelin-1 in angiotensin II-induced contraction of the isolated rat tail artery.

Y Jiang1, C R Triggle.   

Abstract

1. The contribution of endothelin-1 (ET-1) to angiotensin II (Ang II)-mediated contraction of the isolated rat tail artery was assessed with measurements of tension, and cytosolic calcium ([Ca(2+)](i)). The distribution of the AT(1) receptor was studied with RT - PCR and immunohistochemistry. 2. Ang II induced an endothelium-independent contraction (pEC(50) 7.95+/-0.06 and E(max): 0.46 g+/-0.05 with endothelium vs 7.81+/-0.02 and 0.41 g+/-0.07 without endothelium; P>0.05). Ang II (0.003 - 0.3 microM)-induced a non-sustained contraction of endothelium-intact preparations which was not antagonized by BQ-123 (1 microM), but was inhibited by losartan (10 nM). In addition, the maximal contraction induced by ET-1 (0.1 microM) could be further increased by the addition of 0.1 microM Ang II. 3. Ang II (0.001 - 0.3 microM) elevated [Ca(2+)](i) in single vascular smooth muscle cells (VSMCs) in a dose-dependent manner (pEC(50) 9.12+/-0.26) and the Ang II-induced increases in [Ca(2+)](i) were not affected by a Ca(2+)-free solution, but were abolished by pretreatment with caffeine (5 mM). Ang II did not increase [Ca(2+)](i) in endothelial cells. ET-1 (0.1 microM) increased [Ca(2+)](i) in single VSMCs in a normal Ca(2+) containing physiological saline solution (PSS), but not in a Ca(2+)-free solution. 4. Ang II-induced contraction was insensitive to inhibition by nifedipine (0.1 microM), an antagonist of L-type voltage-gated Ca(2+) channels, and SK&F96365 (10 microM), which blocks non-selective cation channels, whereas that to ET-1 was inhibited by SK&F69365. 5. RT - PCR data indicate the expression of AT(1A) and AT(1B) on both VSMCs and endothelial cells, but immunohistochemical evidence illustrates that the AT(1) is located primarily on VSMCs. 6. These results indicate that endothelium-derived ET-1 is not involved in the Ang II-mediated vasoconstriction of the rat tail artery and that Ang II- and ET-1-mediated VSM contractions utilize distinct pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082111      PMCID: PMC1572432          DOI: 10.1038/sj.bjp.0703674

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Proposed update of angiotensin receptor nomenclature.

Authors:  M de Gasparo; A Husain; W Alexander; K J Catt; A T Chiu; M Drew; T Goodfriend; J W Harding; T Inagami; P B Timmermans
Journal:  Hypertension       Date:  1995-05       Impact factor: 10.190

2.  Differential effects of phosphoramidon on contractile responses to angiotensin II in rat blood vessels.

Authors:  L Chen; J R McNeill; T W Wilson; V Gopalakrishnan
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

3.  Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery.

Authors:  C M Boulanger; L Caputo; B I Lévy
Journal:  Hypertension       Date:  1995-11       Impact factor: 10.190

4.  Pharmacological characterization of endothelin-induced contraction in the guinea-pig oesophageal muscularis mucosae.

Authors:  K Uchida; R Yuzuki; Y Kamikawa
Journal:  Br J Pharmacol       Date:  1998-10       Impact factor: 8.739

5.  Inhibition by SK&F 96365 of Ca2+ current, IL-2 production and activation in T lymphocytes.

Authors:  S C Chung; T V McDonald; P Gardner
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

6.  Non-specific effects of calcium entry antagonists in mast cells.

Authors:  D Franzius; M Hoth; R Penner
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

7.  Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin.

Authors:  L Chen; J R McNeill; T W Wilson; V Gopalakrishnan
Journal:  Hypertension       Date:  1995-07       Impact factor: 10.190

8.  Conversion and degradation of [125I] labelled angiotensin I in isolated perfused porcine coronary and carotid arteries.

Authors:  A H Danser; S Chowdury; L M de Lannoy; W J van der Giessen; P R Saxena; M A Schalekamp
Journal:  Cardiovasc Res       Date:  1995-06       Impact factor: 10.787

9.  Pharmacology of a Ca(2+)-influx pathway activated by emptying the intracellular Ca2+ stores in HL-60 cells: evidence that a cytochrome P-450 is not involved.

Authors:  B D Koch; G F Faurot; M V Kopanitsa; D C Swinney
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

10.  Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.

Authors:  D E Vaughan; S A Lazos; K Tong
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

View more
  2 in total

Review 1.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

2.  Reduction of blood pressure by store-operated calcium channel blockers.

Authors:  Yan-Jun Xu; Vijayan Elimban; Naranjan S Dhalla
Journal:  J Cell Mol Med       Date:  2015-10-16       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.